SCHEMBL6940914

SCHEMBL6940914

CCCC(C[C@@H](C/C=C\c1nccs1)C(=O)OC(C)(C)C)C(=O)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
GRIK1 P39086 2/20 0.32
GRIK2 Q13002 2/20 0.32
SLC1A3 P43003 1/20 0.32
SLC1A2 P43004 1/20 0.32
SLC1A1 P43005 1/20 0.32
FFAR2 O15552 1/20 0.31
CHRM1 P11229 1/20 0.31
AKR1A1 P14550 1/20 0.31
CHRM3 P20309 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
ADRA1A P35348 1/20 0.31
HRH1 P35367 1/20 0.31
DRD3 P35462 1/20 0.31
SLC6A3 Q01959 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6940918 1.00 CYP1A2 (0.32) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL6940923 0.80 L3MBTL1 (0.34) CTSKL3MBTL1
SCHEMBL27487428 0.80 L3MBTL1 (0.34) CTSKL3MBTL1
SCHEMBL27487429 0.77 CTSL (0.30) CTSLCTSSCTSKL3MBTL1
SCHEMBL6940925 0.77 CTSL (0.30) CTSLCTSSCTSKL3MBTL1
SCHEMBL6374183 0.66 TDP1 (0.37) CYP1A2CYP3A4CYP2C9CYP2C19FFAR2
SCHEMBL6374179 0.66 TDP1 (0.37) CYP1A2CYP3A4CYP2C9CYP2C19FFAR2
SCHEMBL28146565 0.66 CTSK (0.45) CYP3A4GRIK1GRIK2CHRM1AKR1A1
SCHEMBL14443175 0.65 METAP1 (0.36) TDP1
SCHEMBL13601089 0.65 METAP1 (0.36) TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0993442-B1 HYDRAZINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2003-04-23 EP disclosed
US-6235787-B1 ANTIINFLAMMATORY AGENTS; RHEUMATIC DISEASES; BONE DISORDERS; SKIN DISORDERS; MULTIPLE SCLEROSIS HOFFMANN-LA ROCHE INC. 2001-05-22 US disclosed